This inventor holds 1 USPTO granted patent. Top assignee: Sugen Incorporated. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations of Chung Chun Wei in Kinase Inhibition
Introduction
Chung Chun Wei is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of kinase inhibitors. His work has the potential to impact the treatment of various diseases by modulating protein kinase functions.
Latest Patents
Chung Chun Wei holds a patent for his invention titled "3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors." This invention relates to specific indolinone compounds, their synthesis methods, and a combinatorial library of these compounds. The patent also covers methods for modulating the function of protein kinases using these indolinone compounds, as well as approaches for treating diseases by influencing protein kinase functions and related signal transduction pathways. He has 1 patent to his name.
Career Highlights
Chung Chun Wei is currently associated with Sugen Incorporated, a company known for its innovative research in the field of biotechnology. His work at Sugen has allowed him to explore and develop new therapeutic strategies that could lead to significant advancements in medical treatments.
Collaborations
Chung has collaborated with notable colleagues, including Ping Huang and Todd Anthony Miller. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Chung Chun Wei's contributions to the field of kinase inhibitors exemplify the importance of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.